Clinical Trial 49394

Marlton, NJ 08053


A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of PRX012 in Alzheimer's Disease.

Qualified Participants Must:

• Be 60-85
• Have BMI between 18-32
• Be experiencing memory loss

Qualified Participants May Receive:

  • Compensation for time and travel
  • No insurance necessary and travel included

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.